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Background: C. elegans expresses three 
metabotropic glutamate receptors: mgl-1, mgl-2 
and mgl-3. 
Results:  mgl-1 and mgl-3, but not mgl-2, 
modulate activity in the neural circuit underlying 
feeding behaviour. 
Conclusion: mgl-1 is the major contributor to 
the inhibitory tone of the feeding circuit and 
context-dependent feeding behaviour. 
Significance: C. elegans provides a model for 
systems level understanding of metabotropic 
glutamate receptors. 
 
ABSTRACT 
 Glutamatergic neurotransmission is 
evolutionarily conserved across animal phyla. A 
major class of glutamate receptors are the 
metabotropic glutamate receptors (mGluRs). In 
C. elegans three mGluR genes mgl-1, mgl-2 and 
mgl-3 are organised into three sub-groups, 
similar to their mammalian counterparts. 
Cellular reporters identified expression of the 
mgls in the nervous system of C. elegans and 
overlapping expression in the pharyngeal 
microcircuit that controls pharyngeal muscle 
activity and feeding behaviour. The overlapping 
expression of mgls within this circuit allowed 
investigation of receptor signalling per se and in 
the context of receptor interactions within a 
neural network that regulates feeding. We 
utilized the pharmacological manipulation of 
neuronally regulated pumping of the pharyngeal 
muscle in wild type and mutants to investigate 
mgl function. This defined a net mgl-1 
dependent inhibition of pharyngeal pumping 
which is modulated by mgl-3 excitation. 
Optogenetic activation of the pharyngeal 
glutamatergic inputs combined with 
electrophysiological recordings from the isolated 
pharyngeal preparations provided further 
evidence for a presynaptic mgl-1 dependent 
regulation of pharyngeal activity. Analysis of 
mgl-1, mgl-2 and mgl-3 mutant feeding 
behaviour in the intact organism after acute food 
removal identified a significant role for mgl-1in 
the regulation of an adaptive feeding response. 
Our data describes the molecular and cellular 
organisation of mgl-1, mgl-2 and mgl-3.  
Pharmacological analysis identified that in these 
paradigms mgl-1 and mgl-3, but not mgl-2, can 
modulate the pharyngeal microcircuit. 
Behavioural analysis identified mgl-1 as a 
significant determinant of the glutamate-
dependent modulation of feeding, further 
highlighting the significance of mGluRs in 
complex C. elegans behaviour.  
 
INTRODUCTION 
 In mammals glutamate signals broadly 
via two classes of receptor, these are the 
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ionotropic (iGluR) and metabotropic (mGluR) 
glutamate receptors (1,2). Metabotropic 
glutamate receptors (mGluRs) are G-protein 
coupled receptors and perform an important 
neuromodulatory role in glutamatergic 
transmission within the mammalian nervous 
system (3,4). The importance of this class of 
receptor is highlighted by their involvement in a 
number of different neurological conditions, 
including anxiety, autism and schizophrenia 
(5,6). Interestingly, it has been proposed that 
each of these conditions involves a loss of the 
balance between cellular inhibition and 
excitation within the context of discrete 
microcircuits (7-9). As neuromodulators 
mGluRs represent attractive targets to 
manipulate the excitatory-inhibitory balance and 
alleviate the behavioural dysfunction and 
sensory deficits associated with these conditions 
(6,10). Hence, understanding of mGluR 
contribution to the balance of activity within a 
microcircuit is potentially beneficial within the 
broader context of neurological disorders where 
this imbalance has been suggested as an 
underlying cause.  
 Both iGluR and mGluR classes of 
receptor are conserved within the genome of the 
model organism C. elegans. In C. elegans the 
iGluR subfamily is well characterized and 
encompasses mammalian NMDA and AMPA-
like receptors, together with an invertebrate 
specific subgroup of glutamate gated chloride 
ion channels (11). The C. elegans genome 
encodes at least three mGluRs, designated mgl-
1, mgl-2 and mgl-3. Whilst the experimental 
tractability of C. elegans has provided insight 
into the molecular, cellular and functional 
organisation of the iGluR family (11),  
comparatively less is known about the function 
of the MGL class of receptor in C. elegans. The 
identification of mGluRs in invertebrates that are 
closely related to specific vertebrate mGluR 
subtypes suggests that this class of receptor may 
play a similarly important role in signalling and 
adaptive behaviour within simpler organisms 
(12-15). 
 C. elegans displays a number of 
rhythmic behaviours that undergo adaptation and 
are modulated by the activity of simple 
microcircuits, which integrate sensory 
information from both the worms’ external and 
internal environment. A key sensory cue that 
governs the pattern of activity within these 
microcircuits is food (16,17). Indeed, both 
dopaminergic, cholinergic and 5-HT signalling 
via GPCRs has previously been shown to 
contribute to a number of food dependent 
behaviours, which encompass changes in 
patterns of locomotory sub-behaviours and 
pharyngeal function (18-20). Hence, the 
presentation and removal of a sensory cue, such 
as food, represents two very distinct contexts 
which change the worms’ behaviour by separate 
signalling pathways. In C. elegans context-
dependent signalling has been resolved at the 
level of neurons expressed within circuits that 
are responsible for either the detection of 
sensory cues or the integration of sensory signals 
with motor co-ordination. For example, the 
glutamatergic circuitry involved in chemotaxis 
towards an attractant contains both OFF-sensing 
neurons, which are active in the absence of an 
attractant and ON-sensing neurons that are 
active in the presence of an attractant. OFF and 
ON situations represent  distinct contextual 
states and the co-ordinated signalling between 
OFF-sensing and ON-sensing neurons provides a 
mechanism by which C. elegans can initiate 
adaptive changes in behaviour in response to 
contextual changes such as the presentation and 
removal of a sensory cue (21). C. elegans 
feeding behaviour has previously been shown to 
change upon the presentation and removal of 
food (20,22), highlighting that circuits 
contributing to the activity of the pharynx are 
subject to context-dependent signalling. The 
observation that glutamate signalling can 
activate circuits to mimic feeding behaviour in 
the OFF-food state implicates a role for this 
neurotransmitter pathway in the context-
dependent modulation of the pharyngeal nervous 
system
2
. Glutamatergic signalling and specific 
receptors therein may therefore contribute to the 
signalling pathways underlying context-
dependent changes in C. elegans feeding 
behaviour.    
 Here we describe three metabotropic 
glutamate receptors that have a widespread 
expression in the nervous system of C. elegans. 
The mgls appear to be differentially expressed 
exclusively in the nervous system of C. elegans. 
mgl-1, mgl-2 and mgl-3 expression in the 
pharyngeal nervous system suggests their 
involvement in the modulation of pharyngeal 
network activity. Electrophysiological 
recordings on a semi-intact preparation of the C. 
elegans pharynx, combined with the use of 
mGluR agonists and worms with putative null 
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mutations identified that under these 
experimental conditions both mgl-1 and mgl-3, 
but not mgl-2, can modulate the activity of the 
pharyngeal circuit. Experiments performed on 
intact animals suggest that of the three receptors 
mgl-1 makes a significant contribution to 
changes in feeding behaviour upon acute food 
removal and to the context-dependent 
modulation of C. elegans feeding behaviour. 
Overall the results reveal a role for glutamate 
neurotransmission and MGL receptor signalling 
in context-dependent feeding behaviours.  
 
EXPERIMENTAL PROCEDURES 
 
Culturing of C. elegans  
 C. elegans strains were cultured under 
standard conditions (23). Wild-type Bristol N2 
and eat-4(ky5) was obtained from the 
Caenorhabditis Genetics Centre (CGC). The 
strain pha-1(e2123) was obtained from R. 
Schnabel. The putative mgl knockout strains 
mgl-1(tm1811), mgl-2(tm0355) and mgl-
3(tm1766) were obtained from the National 
Bioresources Project (Tokyo women’s Medical 
University, Tokyo), the mgl green fluorescent 
protein (GFP) reporter strain utIs35[mgl-
1::GFP] is a mgl-1::GFP gene fusion under the 
mgl-1 promoter (as described in unpublished 
communication
3
). The mgl mutant strains were 
out-crossed at least 3 times.  
 
Molecular phylogeny of MGL proteins 
 Protein sequences for 77 metazoans with 
sequenced genomes were downloaded from 
Ensembl (Version 61; 3/2/11) (24). In addition, 
Brugia malayi proteins were downloaded from 
Wormbase (13/2/11) (25). Homologues of C. 
elegans MGL-2 (F45H11.4.2) were identified 
from these proteomes using BLAST (26) and the 
protein family constructed with HAQESAC 
(27). Protein alignments were performed with 
MAFFT (28), using default settings. Minimum 
evolution molecular phylogenies were 
constructed using FastTree (29) with 1000 
bootstrap replicates. 
  
RACE, SL-1 and Predictive PCR analysis  
 RACE (rapid amplification of cDNA 
ends) amplifications. Total RNA was extracted 
from mixed stage Bristol N2 animals using a 
TRIzol
®
 (Invitrogen) extraction method. Both 
reverse transcribed mRNA and C. elegans 
cDNA library (Origene) were used as template 
for the various characterization techniques used 
and outlined below. All 5´-RACE products 
analysed in the present study derived from two 
rounds of amplification using a 5´-RACE primer 
in the first reaction and a nested 5´-RACE 
primer in the second reaction as indicated below. 
In contrast, all the analysed 3´-RACE products 
were generated using a single amplification with 
a 3´-RACE primer. For these experiments, 1 µg 
of total RNA was used to perform first-strand 
cDNA synthesis and incorporate either the 5´- or 
3´-RACE adaptor sequence as described by the 
manufacturer (SMART RACE cDNA 
amplification kit; Clontech). The RACE adaptor 
fused first-strand cDNA was used directly as the 
template for RACE PCR. RACE primers were 
designed using the sequence information 
available at the time. The sequence of the 
primers used was as follows: mgl-1 5´-RACE 
(5´-
GATGGCGAGCTCTCGTCATCTGTCATCCT
C- 3´), mgl-1 5´-nested RACE (5´-
GTCATTGTTTCTATCCCACGACTCTGATG
CAAGC-3´), mgl-1 3´-RACE (5´-
CTCCGCCTGGGTCAACGGCATCAAGGTG
C-3´), mgl-2 5´-RACE (5´-
CGATGCTGTTCGTGTGACTCCTCCACCCA
TAC-3´), mgl-2 5´-nested RACE (5´-
GTCGGATAAGTCTGGAGTGGTGGCGGAG
-3´), mgl-2 3´-RACE(5´-
GTCGGAGTTGGTTTGATGCGGGATTGGC
CGGATG-3´), mgl-3 5´-RACE(5´-
GAACCGGAGGAATTGGCACGAAAAATGA
AGAG-3´), mgl-3 5´-nested RACE (5´-
CGGCTCCTGTTGAACTGTAGCTGACTTGA
GG-3´) and mgl-3 3´-RACE (5´-
GAATGGTGACGGAATCGGACGATATGAT
GTCTTC-3´).  
 
C-terminal domain amplification  
 Mixed stage cDNA was used as a 
template in reactions designed to amplify the 
sequences encoding the entire intracellular C-
terminal domain of the receptors. This was done 
with primers encoding the 5´ (5´-CT) end of this 
domain and 3´-end (3´-CT) encoding the last 8–
10 amino acids preceding the predicted stop 
codon. mgl-1 5´-CT (5´-
GAAAAACACAAAAACGTCCGAAAG-3´), 
mgl-1 3´-CT (5´-
TCATAAGAAAGTATCGTGAGC-3´), mgl-2 
5´-CT (5´-CATCCTGAGAAGAATATCAGA-
3´), mgl-2 3´-CT (5´-
TCAAAAGATTTGCTTGAAATC-3´), mgl-3 
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5´-CT (5´-CAACCATACAAAAATGTGAGG-
3´) and mgl-3 3´-CT (5´-
TCAAAGAAAAGTGGAATTAGTGTC-3´).  
 
SL (splice leader) analysis  
 SL primers were designed according to 
the published sequences for SL-1 (splice leader-
1) (5´-GGTTTAATTACCCAAGTTTGAG-3´) 
and SL-2 (splice leader-2) (5´-
GGTTTTAACCCAGTTACTCAAG-3´) 
respectively. These were combined in a standard 
PCR reaction with mgl-1-5´-RACE and mgl-3 
5´-nested RACE as required. All PCRs were 
performed with the enzyme BD Advantage2 
(Clontech). ‘Touchdown’ PCR parameters were 
used for the first round RACE reaction; all other 
PCRs were performed under standard conditions 
(Clontech). The amplified fragments were gel-
extracted (Qiagen) and ligated into a suitable 
vector before sequencing (MWG Biotech). The 
cDNA was aligned to mgl sequences using 
BLASTn (NCBI) and Wormbase. 
 
Rescue experiments 
 The cosmid ZC506 was used to perform 
mgl-1(tm1811) rescue experiments and was 
supplied by the CGC. The cosmid ZC506 (at 10-
15ng/l) was co-injected with the myo-2::GFP 
reporter plasmid pPD11833 (obtained from A. 
Fire) at 20-30ng/l. The expression of GFP in 
the pharyngeal muscle was used to screen for 
transgenic lines expressing ZC506.  
 
Generation of the Peat-4::ChR2;mRFP  
integrated strain 
 ChR2 was amplified from the plasmid 
Pmyo-3::ChR2(H134R);YFP using the primers 
(F) 5’-
CTAGAGACTAGTATGGATTATGGAGGGC
CTG and (R) 5’-ATGGGGTACCTTAG 
GGCACCGCGCCAGCCTCGGCCTC. The (R) 
primer contained a synonymous substitution that 
removed a Kpn-I site internal to ChR2 and 
introduced an artificial stop codon. ChR2 was 
cloned Spe-I/Kpn-I upstream of mRFP in the 
gateway entry vector p-ENTR. This was 
recombined with the gateway destination vector, 
p-DEST., containing 6Kb of eat-4 promoter to 
generate the construct Peat-4::ChR2;mRFP. The 
construct Peat-4::ChR2;mRFP was injected at a 
concentration of 50ng/μl. Lines were established 
from the F2 generation stably expressing mRFP. 
Peat-4::ChR2;mRFP was integrated by UV 
irradiation and outcrossed x6.   
 
Construction of the mgl-2::GFP and mgl-
3::GFP gene reporter 
 For the mgl-2::GFP reporter construct 
the primers 5’-
CATGCATGCAAGCAAACTGAAAATCGCT
CCGTGG and 5’-
CAAGGTACCTTCGCCGCGTTTTTGCTCTT
TTCTAC were used to amplify ~4.5Kb of mgl-2 
promoter, this was cloned into the fire vector 
pPD95-75 using the restriction sites Sph-1/Kpn-
1. Using the primers 5’-
GTTGGTACCAATGGTGTAGCTTGAGACA
GC-3’ and 5’-
CAAGGTACCATGCTCTACAGTCATGTCAC
AC-3’ the full length cDNA encoding MGL-2 
(F45H11.4 in WS243) was amplified, TOPO 
cloned (Invitrogen) and cut using the enzyme 
Kpn-I. The 5’ Kpn-I site was incorporated into 
the 5’ primer, whereas the 3’ site was internal to 
the MGL-2 coding sequence and located within 
the C-terminal. This product was cloned 
downstream of the mgl-2 promoter in the vector 
pPD95-75 using the Kpn-I restriction site to 
generate an MGL-2 protein fusion to GFP at the 
C-terminal. This was injected at 20ng/μl into the 
N2 strain by standard techniques (30).   
 For the mgl-3::GFP reporter construct 
the primers 5-
TTCGTCGACAATAGTATTCCCGAGAACGG 
and 5-
GCGGCCGCTTTTACTGTCGAACTGATTGG 
were used to amplify ~5Kb of mgl-3 promoter 
and the first exon (containing the first putative 
start codon). This fragment was cloned upstream 
of GFP in the vector pHABGFP (provided by 
Howard Bayliss) using restriction sites Sal-I and 
Not-I to generate the construct mgl-3::GFP. This 
was co-injected at 10-20ng/ul with the pha-1 
rescue plasmid pBX (obtained from R. 
Schnabel) into the temperature sensitive strain 
pha-1(e2123) by standard techniques (30). 
Transformed lines were selected at temperature 
sensitive conditions (25.5
o
C). 
 
Imaging of the mgl::GFP reporter strains 
 Animals were mounted in a 5μl drop of 
10mM levamisole (Sigma) on a 2% agarose pad 
covered with a 24x24mm coverslip. Differential 
interference contrast (DIC) and fluorescence 
imaging was performed on a Nikon Eclipse 
TE800 fluorescence microscope equipped with a 
Hamamatsu C4742-95 Digital Camera. Confocal 
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images were captured with a Zeiss LSM- 510 
laser-scanning microscope. 
 
Electropharyngeogram (EPG) Recordings 
 Hermaphrodite animals were grown on a 
bacterial lawn of OP50 and young adults were 
picked for electrophysiological experiments. 
Animals were placed into a Petri dish containing 
modified Dent’s saline (composition in mM: 
Glucose 10, HEPES 5, NaCl 140, KCl 6, CaCl2 
3, MgCl2 1 and pH7.4) supplemented with 
Bovine Serum Albumin (0.1% w/v). Worms 
were dissected by cutting them at the 
pharyngeal-intestinal valve with a razor blade, 
causing the cuticle to retract and exposing the 
isthmus and terminal bulb to generate a semi-
intact pharyngeal preparation in which the 
pharyngeal microcircuit remains intact. The 
dissected preparation will have a distinct 
physiology to the intact organism, where the 
somatic nervous system is completely intact. All 
experiments were performed at room 
temperature ( 20-22oC). The pharyngeal 
preparation was transferred to a custom made 
recording chamber (volume 1mL) mounted on a 
glass coverslip. Suction pipettes were pulled 
from borosillicate glass (glass diameter 1mm; tip 
diameter 12μm; Harvard Instruments). The 
pipette was lowered into the recording chamber 
and placed close to the anterior end of the 
preparation. Suction was then applied to attach 
the preparation to the pipette. The suction pipette 
was attached to an Axoclamp 2B recording 
amplifier. The reference electrode was a silver-
chloride pellet in Dent’s saline connected to the 
recording chamber by an agar bridge. 
Extracellular voltage recordings were made in 
“bridge” mode and the extracellular potential 
was set to 0 mV using the voltage off-set 
immediately prior to recording. Data was 
acquired using Axoscope (Axon Instruments) 
and stored for subsequent off-line analysis. 
 In single dose experiments the 
recordings were made from the pharynxes in 
Dent’s saline for 5 min. The drug was then 
applied to the semi-intact pharyngeal preparation 
by removing and replacing the solution with a 
1mL pipette. Recordings were made from the 
pharynx in the presence of drug for 5 min and 
then the drug was washed off. The frequency of 
the EPGs was measured for the 5 min before 
drug application and for 5 min after the drug 
application. The drug was then washed off the 
preparation. After the drug was washed off the 
preparation the EPGs were measured for a 
further 5 min in Dent’s saline. Following the 5 
min recovery period in Dent’s saline 500nM 5-
HT was applied by removing and replacing the 
Dent’s with a 1ml pipette. EPGs were measured 
for a further 2½ min in the presence of 5-HT. 
The duration of the entire experiment for a 
single worm did not exceed 25 minutes, 
including the time taken to dissect the worm 
pharynx and apply the suction electrode. 
 The LCCG-I concentration response 
curve was generated by sequentially applying 
increasing concentrations of drug to the 
dissected semi-intact pharynxes. The addition of 
each concentration was preceded by a 5 min 
recovery period in Dent’s saline. The drug was 
applied for 2.5 min and the EPGs were measured 
during this period. The effect of the drug on the 
frequency of pharyngeal EPGs is expressed as a 
percentage change compared to the basal resting 
rate during the 2½ min immediately before the 
addition of the drug. The duration of the entire 
experiment for a single worm did not exceed 
77.5 minutes for mgl-1and 62.5 minutes for N2 
including the time taken to dissect the worm 
pharynx and apply the suction electrode.                
 
Intracellular Recordings 
 The dissected pharynx was transferred to 
a custom-built perfusion chamber, volume 1 mL, 
on a glass cover slip. The recording chamber 
was mounted on a microscope stage and 
perfused via gravity feed with saline at a rate of 
20 mL min
-1
. The preparation was secured with a 
glass suction pipette applied to the terminal bulb 
region of the pharynx and then impaled with an 
aluminosilicate glass microelectrode, 1.0 mm 
outer diameter pulled on a microelectrode puller 
to tip with resistance 60-80 MΩ, filled with 4 M 
potassium acetate and 10mM KCl, and 
connected to an Axoclamp 2A amplifier. The 
reference electrode was a silver chloride-coated 
silver pellet in 3M KCl connected to the 
recording chamber by an agar bridge. Data was 
acquired and analyzed using PClamp8 (Axon 
Instruments). Drug solutions were diluted with 
Dent’s saline from stocks as required.  
 
Electrophysiological recording of the Peat-
4::ChR2;mRFP  light evoked response 
 The strains N2;Is[Peat-4::ChR2;mRFP], 
mgl-1(tm1811);Is[Peat-4::ChR2;mRFP] and 
eat-4(ky5);Is[Peat-4::ChR2;mRFP] were 
subjected to pharyngeal dissection as in (31). 
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Desheathed pharynxes were placed in a 
recording chamber and illuminated using a blue 
LED, with wavelength 470nM (as described in 
(31)). Intracellular recordings of muscle action 
potentials were recorded from the terminal bulb 
using sharp electrodes (as described above). For 
N2;Is[Peat-4::ChR2;mRFP] and mgl-
1(tm1811);Is[Peat-4::ChR2;mRFP] recordings 
were made in the presence and absence of 
LCCG-I. The last 10 light stimuli, for each phase 
of the experimental time course were analysed.  
    
Chemicals 
 (±)-1-Aminocyclopentane-trans-1,3-
dicarboxylic acid ((±)trans-ACPD) (Cat#0187), 
and (2S,1´S,2´S)-2-(Carboxycyclopropyl)glycine 
(LCCG-I) (Cat#0333) were obtained from Tocris 
Biosciences (Bristol, UK). All other chemicals 
were obtained from either Sigma or Fisher. 
   
Pharyngeal Pumping Assays in Intact 
Animals 
 A synchronized population of young 
adult worms was generated by picking L4 staged 
animals to a fresh food plate 16-18 hours before 
performing the assay. For each individual animal 
the number of pumps performed within 1 minute 
on food was counted, the food was then removed 
by placing the animal onto a fresh non-food 
plate and allowing it to move around for 1 
minute. Individual animals were each transferred 
to a separate, second non-food plate and the 
number of pumps (defined as the number of 
backwards movements of the terminal bulb 
grinder) performed in 1 min was counted at two 
time points, 5 min and 95 min following the 
transferral. Then after 96 min worms were 
returned to food and at 100 min the pharyngeal 
pumping was recorded.   
 
Data Analysis 
 The results are expressed as the 
percentage change in frequency ± s.e.m of the 
mean for n individual pharynxes. For the EPG 
recordings each drug was tested on a separate 
pharynx. Significance was measured using one- 
way ANOVA, with Bonferroni post-test, unless 
otherwise stated. Concentration-response curves 
were plotted by fitting the data to the modified 
logistic equation (GraphPad Prism, San Diego, 
CA), and EC50 values are given with 95% 
confidence limits.   
RESULTS 
 
Molecular organization of MGL subtypes 
 A combination of PCR-mediated 
approaches (RACE, SL-1/2 amplifications and 
predictive PCR; see methods for further details) 
were applied to either of two cDNA pools 
independently prepared from mixed stage 
animals (see methods) to characterize the 5 and 
3 ends of the mgl cDNAs. The combined 
findings of these different approaches is 
published elsewhere (32) and are presented in 
summary here, together with a revised 
annotation for mgl-2 based upon further analysis. 
The mgl-1 gene encodes at least 3 different 5 
isoforms two of which are alternatively trans-
spliced to SL-1, the nematode specific trans-
splice leader. One of the SL-1 trans-spliced 
variants supports the 5’ gene structure currently 
defined for ZC506.4b. The other SL-1 trans-
spliced variant (European Nucleotide Archive 
Accession#: LN681209)  and 5’RACE analysis 
(European Nucleotide Archive Accession#: 
LN681208) identified alternative 5’ gene 
structure (Figure 1). The sequence of the 
putative signal peptide predicted from the 
translated 5 cDNA sequences of each of the 
mgl-1 isoforms suggests that each of the 5’ 
variants use the same ATG as their start codon.  
The 3’RACE amplification identified a single 
mgl-1 C-terminal variant and redefines exon 11 
of ZC506.4b (European Nucleotide Archive 
Accession#: LN681210) (Figure 1).   
 A single mgl-2 5 isoform was identified 
that was not trans-spliced to SL-1 sequence 
(attempts to amplify mgl-2 5 cDNA using SL-1 
and SL-2 complementary primers were 
unsuccessful). The 3 cDNA analysis suggests 
mgl-2 encodes at least two different 3 isoforms. 
Predictive PCR identified that alternative 
splicing creates a long and a short C-terminal 
variant (denoted mgl-2i and mgl-2ii 
respectively). The long C-terminal variant (mgl-
2i) corresponds to the transcript currently 
defined in Wormbase (transcript F45H11.4, 
Wormbase version WS243). The 3 RACE 
analysis covered an extended region of the mgl-2 
gene compared to the predictive PCR and 
confirmed the alternative splicing in mgl-2ii 
(Figure 1). In our analysis we identified the ORF 
of mgl-2ii and the downstream gene, maf-1 were 
contained within a single transcript. This was 
confirmed by the amplification of a single 
transcript using primers designed against the 
maf-1 3’ end and mgl-2 5’UTR. Sequencing of 
this transcript confirmed both the alternative 
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splicing in mgl-2ii and a 4 nucleotide overlap 
(ATGA) between the 3’ end of mgl-2ii and the 
5’ end of maf-1, which contains the putative 
TGA stop codon for mgl-2ii and the putative 
ATG start codon for maf-1 (European 
Nucleotide Archive Accession#: LN681207). 
The ORF of mgl-2ii and maf-1 were not in-frame 
with each other and in-silico translation in their 
respective reading frames each gave rise to 
bona-fide protein sequence.     
 At least two different mgl-3 5 isoforms 
were identified, the difference being that one 
variant was SL-1 trans-spliced (European 
Nucleotide Archive Accession#: LN681212), 
whilst the other contained a predicted 
untranslated exon within the 5 promoter region, 
located 15Kb upstream of the first coding exon 
(European Nucleotide Archive Accession#: 
LN681211) (Figure 1). The analysis of the C-
terminal of mgl-3 suggests that it undergoes 
alternative splicing, giving rise to at least three 
different C-terminal splice variants (mgl-3i/ii/iii) 
(Figure 1). In mgl-3ii (European Nucleotide 
Archive Accession#: LN681214).  exon 16 uses 
an alternative splice donor site to mgl-3i/iii that 
incorporates 6 additional nucleotides that are 
otherwise intronic in mgl-3i (European 
Nucleotide Archive Accession#: LN681213).  
and mgl-3iii (European Nucleotide Archive 
Accession#: LN681215).The result of this is the 
substitution of a threonine residue for the amino 
acid triplicate IleSerAla. Other than this the 
sequence of the mgl-3i/ii 3 cDNA region that 
was PCR amplified was the same. In mgl-3iii 
alternative splicing caused a frame-shift in the 
downstream open reading frame and the 
introduction of an alternative stop codon. The 
isoform mgl-3iii has been independently 
identified by the EST submission EC001043. 
The 3’ RACE analysis of the mgl-3 C-terminal 
confirmed the mgl-3i splice variant (European 
Nucleotide Archive Accession#: LN681216).  
 The molecular phylogeny of the MGR 
family provided in this study is an updated 
analysis and a further clarification of that 
previously published in (32). It supports the 
assignment of the three nematode MGL proteins 
to the three mammalian MGR types (Figure 2). 
MGL-2 forms a well-supported clade with 
vertebrate Group I (>99% bootstrap support). 
MGL-1 has previously been classified weakly as 
Group I-like (32,33) but phylogenetic analysis 
(and BLASTP results) show that it is actually 
more closely related to vertebrate Group II 
sequences (>97% bootstrap support). MGL-3 is 
most similar to Group III sequences (Figure 2; 
>80% bootstrap support). Although none of the 
insect species with fully sequenced genomes to 
date have all of the MGR types, sequences from 
different insects indicate that there may be four 
subfamilies. mGluRB (FBpp0271833) (also 
known as DmXR or mangetout), is not a 
glutamate receptor, however, and it has been 
suggested that it has diverged from the rest of 
the family to recognise a different ligand that is 
not a natural amino acid (34). It is not known 
whether the sea urchin orthologue 
(SPU_017426tr) is recognised by glutamate but 
the topology and presence of four echinoderm 
GluR sequences is consistent with this “Group 
X” subfamily being lost in the chordate lineage, 
rather than gained in the insect lineage. 
Although not conclusive, this analysis suggests 
that Group X is most closely related to Group III 
(77% bootstrap support). Consistent with 
previous studies in C. elegans, none of the fully 
sequenced nematodes analysed had a Group X 
receptor. 
  
Distinct and overlapping expression patterns 
for the 3 mgls in C. elegans  
 To assess and compare the expression 
patterns of each of the three mgls  in C. elegans 
transgenic animals, expressing 
extrachromosomal fusions to GFP, were 
constructed for mgl-2 and mgl-3 (see methods). 
For mgl-1 a gene fusion to GFP was 
independently generated (see methods) and 
analysis was performed on animals stably 
expressing the mgl-1::GFP as an integrated 
array. Of the three receptors, mgl-1 appeared to 
have the most widespread expression pattern. 
The reporter mgl-1::GFP was extensively 
expressed in the nerve-ring, in tail neurons and 
extensively within the pharyngeal nervous 
system, which included the neurosecretory 
motorneuron NSML/R, interneurons and 
motorneurons (Figure 3 A –C). In worms 
expressing mgl-2::GFP as an extra-
chromosomal array GFP fluorescence was 
identified in the nerve ring, tail neurons and the 
pharyngeal nervous system, where it was 
expressed in NSML/R (Figure 3 D-F). The 
analysis of mgl-2::GFP transgenic lines also 
identified GFP expression in the glutamatergic 
pharyngeal neuron I5, anterior and posterior 
intestine, pharyngeal-intestinal valve and 
pharyngeal muscle. However, the expression of 
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GFP in these tissues was not consistent between 
transgenic lines analysed. In worms expressing 
mgl-3::GFP as an extra-chromosomal array GFP 
fluorescence was detected in the pharyngeal 
nervous system, specifically NSML/R and in the 
nerve ring (Figure 3G).  
 
Pharmacological characterization of mgls 
using EPG recording in the pharynx 
 To further investigate if mgl receptors 
control pharyngeal pumping an 
electrophysiological assay was developed using 
mGluR agonists that have a well characterized 
efficacy at mammalian mGluRs (35) and have 
previously been shown to exert activity on 
invertebrate nervous systems (14,15). 
 The electropharyngeogram (EPG) is an 
extracellular recording technique that enables the 
detection of electrical transients in the 
pharyngeal muscle and associated circuit of 20 
neurons, which are embedded underneath the 
basement membrane. The myogenic activity of 
the pharyngeal muscle is modulated by the 
activity of the pharyngeal nervous system (36). 
In the experiments described here an incision is 
made at the pharyngeal-intestinal valve leading 
to the extrapharyngeal nervous system being 
displaced (Figure 4A) and leaving the embedded 
pharyngeal neurons which express mgl-1, mgl-2 
and mgl-3. This ensures that the drug response is 
driven either by the action of receptors expressed 
in pharyngeal neurons or by direct activation of 
the underlying pharyngeal muscle.  
 EPG recordings were made from wild-
type animals to look at the effect of mammalian 
mGluR agonists on the electrophysiology and 
pumping behaviour of the pharynx (Figure 4). 
(±)trans-ACPD is a  mammalian mGluR agonist 
with broad spectrum activity against the  distinct 
sub classes of receptor (35). Pharmacological 
profiling of representative mGluR group 
members suggests (±)trans-ACPD is a potent 
agonist of Group I (EC50= 15M at mGluR1) 
and Group II receptors (EC50= 2M at mGluR2) 
and a weak agonist at Group III receptors 
(EC50=800M at mGluR4)(35).  
 Initially 100M (±)trans-ACPD was 
applied to the wild-type preparation. (±)trans-
ACPD is an equimolecular mixture of 
(1S,3R)- and (1R,3S)-ACPD and a selective 
agonist for mGluRs. A variable response was 
obtained that consisted of a large increase, no 
change or an inhibition of the basal pumping 
frequency (data not shown). At the increased 
concentration of 500M, which is more in 
keeping with the EC50 of this agonist at Group 
III mGluRs, (±)trans-ACPD consistently caused 
a reversible inhibition of basal pumping in wild-
type pharynxes (Figure 4B). In a high proportion 
of animals a rebound excitation was recorded 
during the first few minutes of the recovery 
period, after the drug was washed off (Figure 
4B). The neurotransmitter 5-HT is known to be a 
potent stimulator of pharyngeal pumping 
(37,38). Following the wash period 500nM 5-HT 
was applied to assess the viability of the pharynx 
at the end of the recordings. In each recording 
the application of 500nM 5-HT caused a potent 
stimulation of pharyngeal pumping, confirming 
the pharyngeal circuit was still capable of high 
frequency pumping after (±)trans-ACPD had 
been applied and following a 5 minute wash 
period (Figure 4B). LCCG-I is a more 
potent broad spectrum mGluR agonist than 
(±)trans-ACPD and has a higher potency at 
mGluR II and III subgroups. The EC50 at 
representative Group I, II and III mGluRs is 
50M (mGluR1a), 1M (mGluR3) and 9-50M 
(mGluR4a) respectively (35). The application of 
100M LCCG-I to the wild-type pharynx 
preparation caused a consistent and reversible 
inhibition of the EPGs which was often complete 
for the period of drug exposure (Figure 4C). For 
the same reasons as previously described, 
500nM 5-HT was applied to the pharynx after 
LCCG-I had been applied and after a 5 minute 
wash period. In each recording the application of 
500nM 5-HT caused a potent stimulation of 
pharyngeal pumping, confirming the pharyngeal 
circuit was still viable and retained the 
sensitivity to 5-HT. The EC50 for the inhibition 
of pharyngeal pumping by LCCG-I was 
measured at 3M in the dose response analysis 
(Figure 4D).  
 The intracellular recording configuration  
enables the measurement of pharyngeal muscle 
activity (Figure 4E). Compared to the EPG, it 
provides a more direct measure of pharyngeal 
pumping and its modulation by the embedded 
pharyngeal nervous system.  In such recordings 
10M LCCG-I caused an inhibition of 
spontaneous action potential firing however the 
resting membrane potential (-75mV) was not 
changed by the addition of the drug (Figure 4F). 
The latter supports the expression studies that 
failed to detect receptors in the muscle arguing 
against a direct effect of LCCG-I on this tissue. 
Rather the intracellular recordings indicate that 
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LCCG-I activates receptors that reside within the 
pharyngeal nervous system and modify network 
activity that supports pharyngeal pumping. The 
potency of LCCG-I (EC50 3μM) suggest a 
specificity at the Group II like mgl receptor 
(mgl-1) but we extended the analysis to 
investigate pharmacological activation by 
LCCG-I in the various mgl mutants.  
 
LCCG-I modulation of network activity 
across mgl mutants  
 Deletion alleles exist for each of the 
three mgl receptors; these are mgl-1(tm1811), 
mgl-2(tm0355) and mgl-3(1766). The mutations 
were confirmed by PCR using both genomic 
DNA and cDNA derived from the mgl mutants. 
DNA sequencing of the amplified PCR products 
confirmed that in each case the deletion 
culminates in a putative null (data not shown).  
 To probe the basis of the mGluR agonist 
activity in the wild-type pharyngeal preparation 
EPGs were conducted on the mgl mutants in the 
presence of each agonist. (±)trans-ACPD was 
only tested on mgl-1(tm1811) at 500μM and 
pumping by these animals was not impaired as 
in the wild-type, by the drug (data not shown). 
LCCG-I was tested over a range of 
concentrations on each of the mgl mutants 
(Figure 5A, B and C). EPGs by mgl-1(tm1811) 
animals were not inhibited over the range 1-
12.5μM, but at the higher concentrations tested 
(25μM and 100μM) a partial inhibition began to 
be observed (Figure 5D). In contrast to mgl-
1(tm1811), both mgl-2(tm0355) and mgl-
3(tm1766) EPGs were strongly inhibited by 
concentrations of LCCG-I at 3μM and 10μM 
(Figure 5E), suggesting mgl-1 is primarily 
responsible for the LCCG-I response. The wild-
type response of pharynxes to LCCG-I was 
restored in mgl-1(tm1811) by injecting cosmid 
DNA (10-15ng/μL) (Fig 5D) containing the 
entire mgl-1 genomic sequence and 3.6Kb of 
sequence upstream of the first non-coding exon 
defined by RACE analysis (Figure 1). This 
provides further support for the hypothesis that 
mgl-1 is responsible for the inhibitory effect of 
LCCG-I on the pharynx.  
 At the lower range of LCCG-I 
concentrations tested (1μM) an increase in the 
frequency of EPGs was measured from both 
mgl-1(tm1811) and mgl-2(tm0355) (Figure 5D 
and 5E respectively), but not mgl-3(tm1766). 
Instead mgl-3(tm1766) was inhibited by LCCG-I 
without the low dose activation seen at 1µM 
(Fig. 5E). Thus, mgl-3 appears to increase the 
frequency of pharyngeal pumping at low 
concentration. The modulation of the pharyngeal 
network in an mgl-1 and mgl-3 dependent 
manner further supports the expression of these 
receptor subtypes within this microcircuit.   
 
Optogenetic activation of glutamatergic 
evoked activity in the pharyngeal network is 
modulated by LCCG-I. 
 Next we wanted to identify if the 
presynaptic activation of mgl-1 within the 
pharyngeal nervous system inhibited glutamate 
initiated changes in the activity of the 
postsynaptic pharyngeal muscle. Optogenetics 
enables the discrete activation of specific subsets 
of neurons within a network. Hence, an 
optogenetic approach was used to selectively 
depolarise neurons capable of glutamate release 
within this network. Light evoked changes in the 
activity of the pharyngeal network were 
measured by making simultaneous intracellular 
recordings from the pharyngeal muscle, which is 
the postsynaptic target of the pharyngeal neural 
network. This optogenetic electrophysiological 
approach was combined with the 
pharmacological activation of mgl-1 using the 
agonist LCCG-I.        
 The optogenetic depolarisation of 
glutamatergic neurons was achieved by using an 
integrated line in which the light sensitive 
channel rhodopsin (ChR2) was expressed under 
the control of the eat-4 vesicular glutamate 
transporter promoter (Peat-4::ChR2;mRFP). 
The expression of this construct is wide spread 
in the C. elegans nervous system but restricted to 
M3, NSM, I2 and I5 in the pharynx
1
, consistent 
with its expression in the glutamatergic neurons. 
Worms were cultured on NGM plates containing 
retinal, an essential co-factor required for ChR2 
activation. A 1 msec pulse of light (470nm) did 
not excite the exposed pharynx of N2 worms 
that had not been transformed with Peat-
4::ChR2;mRFP (Figure 6A) and (31). Light 
activation of the exposed pharynx of wild-type 
worms expressing Peat-4::ChR2;mRFP  
produced a tightly coupled light  evoked 
excitation in the pharyngeal muscle (Figure 6B). 
The light activated response is initiated from 
the glutamatergic neurons of the circuit 
however the evoked response measured at 
the muscle involves a complex 
depolarization usually followed by a 
superimposed action potential. The 
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complexity of the response arises because 
the pharyngeal glutamatergic neurons 
produce activity in the circuit via gap 
junctions and the release of transmitters in 
addition to glutamate. These interactions are 
the major determinant of the complex 
response that is recorded in the muscle ((31) 
and unpublished observation
1
). This 
expected observation is reinforced by the 
fact that although the light induced response 
is delayed it is not prevented when it is 
triggered in the pharynx of eat-4 mutant 
animals that lack glutamate release but  
retain other  activities independent of 
glutamate release (Figure 6B and 6C) 
 To determine if mgl-1 inhibits the  light 
activated response the optogenetic 
electrophysiological experiments were combined 
with the pharmacological activation of mgl-1. 
10M LCCG-I was bath applied and light 
evoked recordings were made from the exposed 
pharynx of wild-type worms expressing Peat-
4::ChR2;mRFP.  As in the previous 
pharmacological experiments that used intrinsic 
activity, the application of LCCG-I at a dose 
(10µM) that is selective for the mgl-1 mediated 
inhibition caused a reduction in the percentage 
of the light evoked pharyngeal muscle 
depolarization (Figure 7A and 7B). This LCCG-I 
inhibition of the light evoked pharyngeal 
depolarization was reversed upon washout.  The 
LCCG-I often reduced the rise of the light 
induced response but the complex nature of this 
initial depolarization limits the use of this 
parameter as a measure of the drug effect. In 
contrast the inhibition by LCCG-I was clearly 
quantified by comparing the almost complete 
inhibition of the light evoked pharyngeal action 
potentials that were otherwise frequently seen 
when light activation was performed in the 
absence of the drug (Figure 7A and 7B). The 
inhibition of the light evoked pharyngeal muscle 
response by LCCG-I was reversed to almost 
wild-type levels during the wash phase (the basal 
and wash periods were not significantly different 
in a paired Student’s t-test).  
 Light evoked recordings were then made 
from the exposed pharynx of mgl-1 worms 
expressing Peat-4::ChR2;mRFP, in the absence 
and presence of LCCG-I. The percentage of 
stimuli that evoked a full action potential in the 
absence of LCCG-I during the basal period and 
then in the presence of 10μM LCCG-I was not 
significantly different in the mgl-1(tm1811) 
mutant background (Figure 7C).  This suggests 
that mgl-1 activation is largely responsible for 
the LCCG-I mediated inhibition of light evoked 
changes in the network activity.  
 
Modification of modulatory tone associated 
with an adaptive response to food deprivation 
in intact animals lacking mgl subtypes 
 The pharmacological detection of mgl-1 
as an inhibitor of pharyngeal pumping suggests 
it may be involved in the modulation of C. 
elegans feeding behaviour. Experiments in the 
isolated pharynx and whole organism represent a 
significant transition from an in vitro to an in 
vivo analysis. The modulation of the activity in 
the isolated pharynx is largely restricted to the 
embedded pharyngeal nervous system, whereas 
the intact worm will be subjected to additional 
extrapharyngeal regulation in response to 
changes in the external environment. We note 
that the mgl-1 mediated inhibition of pharyngeal 
tone acts at the level of the intrinsic network 
activity, a situation that closely mimics when the 
worm is in an OFF-food state. Hence, we 
designed the whole organism assay around 
comparisons of the worm pharyngeal pumping 
both on and off food. As we have described a 
shift in the tone of the pharyngeal pumping in 
whole worms kept for an increasing period of 
time off food
2
 we conducted off food 
measurements at 5 and 95 minutes. To this end 
we used pharyngeal pumping in the presence of 
food and its response to food deprivation as a 
tractable way to probe for a functional correlate 
of the drug mediated effect.We extended this to 
investigate wild-type animals and compared this 
to mgl-1(tm1811) animals. In addition the single 
mutant’s mgl-2(tm0355), mgl-3(tm1766) and the 
double mutant mgl-1(tm1811);mgl-3(tm1766) 
were included in the analysis to allow us to 
probe for functional evidence of the receptor 
interactions revealed in the semi-intact 
investigation of drug mediated mgl activation. 
Although mgl-2(tm0355) did not display a 
phenotype in the LCCG-I EPG, the expression 
of mgl-2 in the pharyngeal circuit suggests that it 
may modulate pharyngeal function and so it was 
included in the analysis.   
 To investigate if the mgl receptors are 
involved in the food adaptive response a paired 
analysis was performed on animals in the 
presence of food and after being deprived of 
food for a short and extended period of time. 
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Pumping was counted for 1 minute at four time 
points, which were 0 min, where the animal is in 
the presence of food, 5 and 95 minutes after 
being transferred to a no-food environment. 
Worms were then returned to a food lawn and 
the pharyngeal pumping rate was counted at 100 
minutes (Figure 8A).  
 The wild-type worms displayed context-
dependent changes in the frequency of 
pharyngeal pumping. Initially a high frequency 
of pumping was recorded in the presence of food 
(268.4 ±3.7 s.e.m). This decreased after 5 
minutes off food and underwent a time-
dependent increase after being off food for 95 
minutes. When placed back on food the pumping 
rate increased towards the high pumping rate 
initially recorded on food, however, it did not 
completely recover (Figure 8B). In the presence 
of food the pumping rate of single and double  
mgl mutants was not significantly different to 
wild-type (Figure 8B). After being food deprived 
for 5 minutes the pumping rate of wild-type 
animals on a no food arena was reduced to 10.85 
±3.23 (s.e.m) pumps min
-1
 (Figure 8B). After the 
same treatment the pump rate of mgl-1(tm1811) 
was significantly higher than N2, 29.11 ±6.09 
pumps min
-1
 (p<0.05). The pump rate of mgl-
2(tm0355) was increased compared to N2 but 
not significantly different. mgl-3(tm1766) pump 
rate was very similar to  wild-type and not 
significantly different. This would suggest mgl-1 
is active during processes that create the acute 
inhibition of pharyngeal pumping in response to 
food removal. The mgl-3 mutants did not exhibit 
this loss of inhibitory tone. This observation is 
consistent with the EPG recordings made from 
mgl-3 mutants which suggest this receptor 
subtype excites pharyngeal pumping in the 
presence of a low concentration of LCCG-I. In 
addition the pump rate of the double mutant mgl-
1(tm1811);mgl-3(tm1766) was not significantly 
different to the wild-type after 5min of food 
removal. This adds further support to the 
hypothesis that mgl-1 and mgl-3 activation has 
opposing effects on the activity of the 
pharyngeal nervous system, where mgl-1 is 
inhibitory and mgl-3 is excitatory.  Following an 
extended period of food removal (95min) the 
pharyngeal pumping rate of the wild-type 
increased to 53.68 ±8 pumps min
-1
 (Figure 8B).  
All of the mgl mutants tested exhibited an 
increased pharyngeal pumping rate after 95min 
relative to counts made at 5 minutes off food. 
None of the rates recorded were significantly 
different to the wild-type. When wild-type 
worms were returned to food after being starved 
for 95 minutes the pharyngeal pump rate 
increased, approaching that initially recorded on 
food. The recovery of the mgl mutant strains was 
not significantly different to wild-type worms 
(Figure 8B). The rate of mgl-3 pumping and 
mgl-1(tm1811);mgl-3(tm1766) pumping was not 
significantly different to the wild-type on food at 
the beginning of the experiment, after 95min off 
food and when returned to food. 
The analysis of context-dependent 
behaviour would suggest the loss of mgl-1 
function has the greatest impact upon the acute 
response to food removal. To confirm the role of 
mgl-1 in the acute response to food removal, the 
pumping rate of the rescue strain mgl-
1(tm1811);ZC506 was measured after 5 min of 
food removal and compared to mgl-1(tm1811) 
and wild-type strains (Figure 8C). The rate of 
pumping of mgl-1 was significantly higher than 
N2, confirming the previous finding. The 
pumping rate of mgl-1(tm1811);ZC506 was not 
significantly different to N2. This further 
supports the role for glutamate in the negative 
regulation of pharyngeal behaviour in response 
to acute food removal in the whole worm. In 
addition it highlights the contribution made by 
mgl-1 in setting the inhibitory tone in response 
to changes in environmental sensory cues and 
the role of this receptor in modulating the 
activity of the pharyngeal neural network.   
 
Discussion  
 
The mgls: a conserved arm of glutamatergic 
transmission in C. elegans 
  Three receptors with the domain 
organization associated with mGluRs are 
annotated in Wormbase. Our characterization of 
the cDNAs was used to better define the coding 
sequence of the annotated genes. When the three 
mgls were compared they showed as much 
homology to each other as they did to the most 
related mammalian mGluRs, arguing that they 
make up a family of receptors encompassing 
three distinct sub-types. This molecular 
organization thus mirrors the situation that 
prevails in the vertebrate nervous system where 
molecular ontogeny into Group I, II and III is 
supported by selective pharmacological 
specificity and downstream signalling. The 
significance of this is that the identified 
molecular diversity of the mgls suggests they 
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have similar potential to diversify signalling 
output from glutamate transmission. It is 
particularly striking that proteins encoding these 
receptors have many of the motifs that impart 
functional regulation at the level of receptor 
phosphorylation and scaffolding that are known 
to further diversify the complexity of mGluR 
signalling (39).  
 
Molecular complexity to extend receptor 
diversity 
 Performing 5’ and 3’ RACE on the 
predicted gene sequences allowed us to resolve 
apparently unappreciated complexity in the 
promoter elements and splice variants within 
coding sequences that can be derived from the 
gene locus of mgl-1, mgl-2 and mgl-3.  In the 
case of gene control our analysis provided more 
precise transcription start sites many of which 
were authenticated by presence of SL1 splice 
leader sequences. This is true for mgl-1, mgl-2 
and mgl-3. In the latter case the RACE revealed 
the existence of a large 5’ intron that interrupted 
an upstream non-coding exon in the 5’ end of the 
gene. This variant was robustly amplified but 
was not preceded by a splice leader and there is 
no intervening gene in this region. The 
amplification of a single transcript, containing 
the open reading frame for both mgl-2 and the 
transcription factor maf-1 further highlights an 
apparent complexity of mgl function. The 
functional relevance of this finding is unclear; 
however it exemplifies the wider theme that 
there is potential for selective elements to 
control the developmental, temporal and spatial 
expression of the receptors.  
 
Widespread and complimentary expression of 
mgls 
 We used available GFP reporter strains 
to visualize the expression of mgl-1 and 
complemented this with constructs designed to 
look at mgl-2 and mgl-3 expression. These 
reporters encompass many key determinants of 
the likely promoter regions and should provide 
rather faithful expression thus suggesting these 
receptors are restricted to the nervous system. 
Nevertheless the potential for further important 
expression beyond that documented by these 
reporters cannot be ruled out, particularly when 
as in the mgl-3 genes there are clearly relatively 
complex promoter sequences.  The expression 
patterns were relatively distinct and all cases 
seemed restricted to the nervous system.   mgl-1, 
mgl-2 and mgl-3 were expressed in the nerve 
ring and they were also expressed in tail 
neurons.   
 mgl-1, mgl-2 and mgl-3 expression 
patterns appeared distinct but there was overlap 
in the case of the pharyngeal nervous system. 
This represents a microcircuit of 20 neurons that 
release a cocktail of fast transmitters and 
neuromodulators that regulate pharyngeal 
pumping. Striking in this was the clear 
overlapping expression of mgl-1, mgl-2 and mgl-
3 in NSM the neurosecretory neuron that 
expresses the stimulatory modulator 5-HT. This 
expression suggested the potential co-ordinated 
use of these receptors in regulation of the 
pharynx. Although NSM is a classic 
neurosecretory 5-HT releasing neuron it 
additionally expresses the vesicular glutamate 
transporter, suggesting the potential to release 
glutamate (40) and other neuropeptide 
modulators (41). Although the expression of 
these mgls in a glutamate releasing neuron 
would support a role as auto receptors the wide 
expression in particularly of mgl-1 highlights 
their potential to act as both pre and postsynaptic 
detectors of glutamate. As detailed by 
comparison of ours (Figure 3) and others (42,43) 
the expression of mgl-1 and mgl-3 extends to a 
number of non-glutamatergic neurons suggesting 
broad potential in regulation of the neuronal 
pharyngeal microcircuit. 
 
Pharmacological dissection of MGL function 
 The expression of mgl-1, mgl-2 and mgl-
3 in the pharynx lent itself to the functional 
investigation of these receptors. None of the mgl 
mutants exhibited a discernible change in their 
pumping per se when measured using 
extrapharyngeal recording of the EPG. In 
contrast activation with two distinct mGluR 
agonists, known to activate invertebrate 
receptors (12,14), produced a dose dependent 
inhibition of pharyngeal function. Importantly, 
this major inhibitory effect was lost in the mgl-1 
mutants and suggests that these agonists lead to 
functionally coupled mgl-1 receptor activation. 
LCCG-I effects were not impacted in the mgl-2 
mutant, suggesting that this receptor subtype 
does not contribute to the agonist mediated 
inhibition of pharyngeal pumping. The 
appearance of an excitatory effect of LCCG-I 
that otherwise inhibits, in the mgl-1 mutants, 
suggests a cross talk with mgl-3. This could arise 
through one cell as both receptors are expressed 
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in NSM where mgl-1 could inhibit and mgl-3 
promotes stimulatory output of this cell. This 
could be readily achieved by each receptor 
having distinct downstream signalling despite 
their shared activation by a common agonist; 
glutamate. This situation is aped in the sensory 
pathway of the worm at the level of ionotropic 
receptor signalling (21). An alternative 
explanation could be that this effect relates to 
differential activation of cells that selectively 
express the receptors. A striking feature of the 
mgl-1 mediated LCCG-1 effects is that it leads 
to a complete but reversible inhibition of 
pharyngeal pumping. One might predict that in a 
structure like the pharynx, which is myogenic 
(36), that it would be difficult to achieve this 
with an agonist that indirectly modulates the 
muscle by neurogenic control. The intracellular 
recordings did not identify a direct effect of the 
mgl agonist on the muscle consistent with an 
indirect effect. A rebound response was 
observed upon removal of the agonist during the 
washout period. Indeed, such a phenomenon has 
been identified as a physiologically relevant way 
of imparting control within important sensory 
pathways including those that signal to higher 
function. In such scenarios the reduction of 
agonist activity can act as a stimulation of 
network activity (44).  Such modulation may 
allow for excitatory signalling in a network, as 
mgl mediated inhibition is tonicaly changed in 
response to chronic changes in circulating 
glutamate. In the context of the pharynx this 
could derive from synaptically released 
glutamate but the pharyngeal neurons are well 
placed to sense changing concentrations of 
metabolites in the pseudocoelomic fluid.  In this 
regard it is interesting to note that chronic effects 
of mgl-1 and mgl-2 have been noted with respect 
to starvation responses (42). This along with 
their conserved role as taste and gustatory 
receptors opens up the potential of pharyngeal 
receptors to co-ordinate nutritional cues as well 
as participating through more classical synaptic 
activation.  
 In a reverberating circuit in which one 
assays the network activity it can be difficult to 
resolve the precise locus of receptor mediated 
inhibition. Indeed, the widespread expression of 
mgl-1 suggests a broad potential for receptor 
activation to act in glutamate releasing/sensing 
neurons. This is borne out by our experiments in 
which we selectively activated the circuit by 
light stimulation of the glutamate releasing 
neurons. This approach resolves a highly 
coupled muscle depolarization which involves a 
post stimulation depolarization with a 
superimposed action potential. The initial event 
is largely dependent on glutamate but appears 
not to be selectively effected by LCCG-1 
mediated mgl-1 activation. In contrast there is a 
more complete inhibition of the super imposed 
action potential which is driven by glutamate 
release onto the muscle and additional 
synaptically driven glutamate events that in turn 
drive cholinergic release in the pharyngeal 
microcircuits. This suggests that mgl-1 could 
potentially act at several loci in the pharyngeal 
microcircuit and cell specific rescue of mgl-1 
function would be required to determine if this is 
an evenly distributed network effect or derives 
from a more discrete determinant. 
 
Regulation of pharyngeal function and 
beyond 
 The analysis of mgl function in the 
pharynx has the virtue of allowing a combination 
of mutants and pharmacological investigation of 
function.  However, this preparation failed to 
resolve a clear difference in the wild-type and 
mutants pharynx with respect to their un- 
stimulated pumping.  For this reason we tested 
the pharyngeal response in the intact animal with 
respect to distinct food stimulation.  
 However, as indicated in the 
pharmacological experiments mgl-1 activation 
produces a potent inhibition of pumping. Thus 
one might predict this receptor mutant would 
display an exaggerated response to food. This 
simple view neglects the possibility that the 
pharyngeal nervous system is additionally 
providing an integrated control of the pharynx in 
the absence of food. This is reinforced by the 
observations in the sensory systems detailing 
acute response to mimics of food removal (21). 
With this in mind we investigated pharyngeal 
pumping on food and at two time points after 
removal from food. These data in the wildtype 
recapitulate observations that suggest that after 
food removal worms stop pumping and slowly 
increase this for up to 90 mins ((45) and 
unpublished observation
2
). Observations that 
receptor activation by modulators and 
neuropeptides inhibits pumping and the data 
reported in this study suggest that the pharynx 
and its embedded microcircuit allows for an 
intricate balance in tone. Mutants that exhibit an 
exaggerated pumping in response to food 
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withdrawal suggest there is a loss of this tone. 
The observation that mgl-1 mutants belong to 
this class suggests that they function in such a 
way and is consistent with the observation that 
pharmacological activation of the receptor leads 
to an inhibition of pharyngeal function.  The 
expression pattern of mgl-1 and the tractable 
effect of mGluR agonists in the isolated 
pharyngeal preparations suggest that mgl-1 could 
exert such an effect at the level of the circuit 
within the intact organism. The exaggerated 
pumping phenotype of mgl-1 was restricted to 
early time-points, following acute food removal 
and the elevated pumping after a prolonged 
period off food was equivalent in all mutant 
backgrounds. These observations highlight the 
selective contribution of mgl-1 at a discrete time-
point of an adaptive response.  
Overall our observations highlight a 
powerful effect of mgl-1 in the modulation of 
pharyngeal pumping behaviour. The modulation 
revealed by pharmacological investigations is 
reinforced by behavioural investigations and 
suggest a wider significance of mgl mediated 
signalling. As highlighted by the molecular 
diversity of C. elegans mgl subtypes this mode 
of glutamate signalling already exhibits 
significant complexity. Thus, C. elegans can 
model fundamental aspects of the key processes 
by which these receptors underpin function in 
higher organisms.  
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FIGURE LEGENDS 
 
Figure 1. Molecular characterisation of the different mgl receptor subtypes. Exon-intron 
boundaries characterised by the analysis of SL-1 PCR amplified and RACE amplified cDNA 
fragments are shown for each mgl subtype. For comparison the gene models annotated by Wormbase 
version WS243 are shown. () SL-1 trans-splice site () alternative splice donor site leading to a 6 
nucleotide insertion. The position of the putative maf-1 ATG start codon is indicated in the diagram of 
the mgl-2 gene models. White boxes represent 5’ and 3’ untranslated regions. Scale bars: 500bp  
 
Figure 2. Unrooted molecular phylogeny of the mGluR family with subfamily clades 
represented by single branches for clarity. The root position using vertebrate taste receptors as an 
outgroup (not shown) is indicated with a filled arrow. The position given by midpoint rooting of the 
mGluR family alone is indicated with an open arrow. Bootstrap values for the main MGR groups are 
shown (1000 replicates). Vertebrate mGluR GRM1-8, nematode MGL1-3 and Drosophila mGluRA 
and mGluRB are labelled. Other sequences are indicated with taxa only. 
 
Figure 3.  The mgl subtypes have distinct and overlapping expression patterns in the C. elegans 
nervous system. The expression of mgl-1::GFP is widespread, in neurons located in A. The nerve 
ring and B. the tail. De-sheathing the pharynx by removing the overlaying cuticle and muscle 
identified mgl-1::GFP expression in neurons of the pharyngeal nervous system C.  mgl-2::GFP 
fluorescence was recorded in D. the nerve ring, E the tail and F the pharyngeal nervous system. mgl-
3::GFP fluorescence was observed in G. the nerve ring and the pharyngeal nervous system and H. the 
tail. The white dotted lines indicate the outer perimeter of the preparation of the whole worm (A, B, 
D, E, G, H) and the unsheathed pharyngeal preparation (C, F). Each of the mgl subtypes is expressed 
in the pharyngeal NSM neurons, indicated by the white arrow heads. 
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Figure 4. Selective mGluR agonists trans-ACPD and LCCG-I both inhibit the activity of the 
pharyngeal neuromuscular network. A. EPG recording configuration from the semi-intact 
pharyngeal preparation.Trace B. and C. each show an EPG recorded from individual pharynxes of 
wild-type worms. Each deflection represents a single pharyngeal pump (because of the long time-base 
individual pumps cannot always be resolved if the pumping activity is fast). The period of drug 
application is indicated on individual recordings. D. Concentration-response curve for the effect of 
LCCG-I on the percentage change in the rate of pharyngeal pumping recorded in the EPG 
configuration. Each point is the mean  s.e.m of n = 9 determinations. E. Intracellular recording 
configuration to measure pharyngeal muscle activity. F. The effect of 10M LCCG-I on the 
frequency of pharyngeal action potentials recorded intracellularly from the C. elegans pharyngeal 
terminal bulb muscle. The period of drug application is indicated on the recording by the solid black 
line, with the concentration indicated beneath.   
 
Figure 5. The effects of LCCG-I on the EPG recorded from the pharyngeal muscle of mgl 
receptor subtype mutants. A-C, EPG’s recorded from individual mgl mutant pharynxes. The point 
of LCCG-I drug application is indicated on individual recordings by solid lines, with the 
concentration indicated beneath. D. Concentration-response of mgl-1(tm1811) and the genomic rescue 
mgl-1(tm1811);ZC506 (the wild-type response is included for comparison). For mgl-1(tm1811) each 
point is the mean  s.e.m of n = 12 determinations. For mgl-1(tm1811) genomic rescue 10 individual 
pharynxes were tested (5 from each of two stable transgenic lines transformed with ZC506). Each 
point is the mean  s.e.m of n = 10 determinations. E. Concentration-response for the effects of 
LCCG-I on mgl-2(tm0355) and mgl-3(tm1766). Each point is the mean  s.e.m of n = 6 
determinations for mgl-2(tm0355) and n = 5 for mgl-3(tm1766).  
 
Figure 6. A comparison of excitatory pharyngeal muscle responses in the desheathed 
pharyngeal preparation of wild-type (N2) and glutamate deficient (eat-4) worms following 
optogenetic activation of glutamatergic pharyngeal neurons. A. A representative trace to show 
that a 1 msec pulse of blue light (470nm) did not excite the pharynx of N2 worms that do not express 
Peat-4::ChR2;mRFP. The stimulus is indicated in the trace below the voltage response recorded from 
the muscle. B. Representative traces of the light stimulated postsynaptic potentials recorded from the 
pharyngeal muscle of N2 and eat-4(ky5) worms expressing Peat-4::ChR2;mRFP. Note that the 
postsynaptic response still occurs in eat- 4(ky5) but the latency is longer. C. The latency of the light 
activated PSP is significantly longer in eat-4(ky-5) compared to N2. eat-4(ky5);[Peat-4::ChR2;mRFP] 
(n = 8) and N2;[Peat-4::ChR2;mRFP] (n = 14). Results are presented as the mean ± s.e.m. **p<0.01 
in an unpaired Student’s t-test.    
 
 
Figure 7. The effect of LCCG-I on light evoked post-synaptic potentials in the desheathed 
pharyngeal preparation of wild-type and mgl-1(tm1811) worms. A. Representative light evoked 
post-synaptic responses in N2 wild-type worms expressing Peat-4::ChR2;mRFP before, during and 
after the application of 10µM LCCG-I. The stimulus is indicated in the trace below the voltage 
response recorded from the muscle.  Quantification of the LCCG-I inhibition of full action potentials 
evoked by light activation of Peat-4::ChR2 in B. wild-type (n = 10) and C. mgl-1(tm1811) (n = 7) 
worms.  A post-synaptic potential was considered to be light-evoked if it occurred within 50msec of 
the stimuli, otherwise it was considered as arising from the spontaneous intrinsic activity of the 
pharynx and not included in the analysis.  
 
Figure 8. The effect of acute and longer term food deprivation upon the regulation of 
pharyngeal pumping in mgl mutant animals. A. A diagram indicating the time line of the 
pharyngeal pumping assay. B. The rate of pumping on and off food at the time points indicated in 
Figure A for N2 (n = 39), mgl-1(tm1811) (n = 27), mgl-2(tm0355) (n = 28), mgl-3(tm1766) (n = 17) 
and mgl-1(tm1811);mgl-3(tm1766) (n = 30). Significance was determined using the one-way ANOVA 
and Bonferroni post-test comparisons to compare mgl mutant pumping to wild-type pumping. 
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*p<0.05 in Bonferroni post-test comparisons. C. The rate of pumping 5 minutes after removal from 
food to assess rescue against the mgl-1 exaggerated OFF-food phenotype by the cosmid ZC506. N2 (n 
= 15), mgl-1(tm1811) (n = 15) and the rescue mgl-1(tm1811);ZC506 (n = 15). Significance was 
determined using an unpaired Student’s t-test to compare mgl-1(tm1811) and mgl-1(tm1811);ZC506 
to wild-type pumping.  
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